Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.40 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23021653 | 0.88 | GLA (0.37) | GLAHSD11B1L3MBTL1HTTKDM4E | |
| SCHEMBL10323133 | 0.83 | GLA (0.41) | GLAHSD11B1L3MBTL1HTTKDM4E | |
| SCHEMBL5396085 | 0.79 | HSD11B1 (0.45) | GLAHSD11B1L3MBTL1HTTKDM4E | |
| SCHEMBL17636389 | 0.78 | HSD11B1 (0.53) | HSD11B1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL14455208 | 0.78 | HSD11B1 (0.53) | HSD11B1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL159741 | 0.78 | HSD11B1 (0.53) | HSD11B1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL19557166 | 0.78 | HSD11B1 (0.48) | GLAHSD11B1L3MBTL1HTTKDM4E | |
| SCHEMBL12714 | 0.78 | HSD11B1 (0.48) | GLAHSD11B1L3MBTL1HTTKDM4E | |
| SCHEMBL19557168 | 0.78 | HSD11B1 (0.48) | GLAHSD11B1L3MBTL1HTTKDM4E | |
| SCHEMBL7921622 | 0.77 | ALDH1A1 (0.48) | GLAHSD11B1L3MBTL1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1885680-B1 | PROCESS FOR THE PREPARATION OF ADAMANTANE DERIVATIVES | Cabb finland oy (FI) | 2014-03-26 | — | — | EP | claimed |
| CN-103304406-A | Preparation method of 2-(1-adamantly) glyoxylic acid | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-09-18 | — | — | CN | claimed |
| EP-2611770-A1 | PROCESS FOR THE REDUCTIVE AMINATION OF -KETO CARBOXYLIC ACIDS | Sandoz AG (CH) | 2013-07-10 | — | — | EP | claimed |
| WO-2012028721-A1 | PROCESS FOR THE REDUCTIVE AMINATION OF α-KETO CARBOXYLIC ACIDS | SANDOZ AG (CH) | 2012-03-08 | — | — | WO | claimed |
| CN-101193847-B | Process for producing adamantane derivative | CABB OY | 2012-02-29 | — | — | CN | claimed |
| JP-2008542343-A | — | — | 2008-11-27 | — | — | JP | claimed |
| CN-101193847-A | Process for producing adamantane derivative | KEMFINE OY (FI) | 2008-06-04 | — | — | CN | claimed |
| EP-1885680-A1 | PROCESS FOR THE PREPARATION OF ADAMANTANE DERIVATIVES | Kemfine oy (FI) | 2008-02-13 | — | — | EP | claimed |
| US-7205432-B2 | Process for the preparation of adamantane derivatives | KEMFINE OY (FI) | 2007-04-17 | — | — | US | claimed |
| WO-2006128952-A1 | PROCESS FOR THE PREPARATION OF ADAMANTANE DERIVATIVES | KEMFINE OY (FI) | 2006-12-07 | — | — | WO | claimed |
| US-20060270870-A1 | Process for the preparation of adamantane derivatives | KEMFINE OY (FI) | 2006-11-30 | — | — | US | claimed |
| CN-119798213-A | Alpha-hydroxycarboxylic acid derivative with adamantyl, and preparation method and application thereof | 黄淮学院 | 2025-04-11 | — | — | CN | disclosed |
| US-20250075199-A1 | Immobilized Enzyme and Application thereof in Continuous Production | ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD. (CN) | 2025-03-06 | — | — | US | disclosed |
| CN-118880359-A | Alpha-ketoamide derivative and preparation method thereof | 济宁学院 | 2024-11-01 | — | — | CN | disclosed |
| EP-4438723-A1 | IMMOBILIZED ENZYME AND USE THEREOF IN CONTINUOUS PRODUCTION | Asymchem Life Science (Tianjin) Co., Ltd (CN) | 2024-10-02 | — | — | EP | disclosed |
| EP-1885680-A1 | PROCESS FOR THE PREPARATION OF ADAMANTANE DERIVATIVES | Kemfine oy (FI) | 2008-02-13 | — | — | EP | disclosed |
| US-7205432-B2 | Process for the preparation of adamantane derivatives | KEMFINE OY (FI) | 2007-04-17 | — | — | US | disclosed |
| WO-2006128952-A1 | PROCESS FOR THE PREPARATION OF ADAMANTANE DERIVATIVES | KEMFINE OY (FI) | 2006-12-07 | — | — | WO | disclosed |
| US-20060270870-A1 | Process for the preparation of adamantane derivatives | KEMFINE OY (FI) | 2006-11-30 | — | — | US | disclosed |
| US-20050260712-A1 | Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor | ASTRAZENECA AB (SE) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060270870-A1 | Process for the preparation of adamantane derivatives | HAAO, HAO1, HAO2 | GLA 352/4885HSD11B1 55/4885L3MBTL1 4808/4885 |
| US-20050260712-A1 | Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor | DNPEP, DPP4, PEPD | GLA 3582/4885HSD11B1 1012/4885L3MBTL1 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.